A 16-week trial shows daily 60g peanut intake may alter brain insulin sensitivity in older adults, particularly in memory-related regions like the…
On October 20, the FDA cleared bepirovirsen, marketed as Hibsago, for use in adults battling chronic hepatitis B virus (HBV). This drug,…
New treatments for generalized myasthenia gravis that offer improved disease control and reduced corticosteroid side effects.
Boehringer Ingelheim's obesity drug trial results show a 13.1% weight loss, a disappointing outcome in the competitive market dominated by Eli Lilly…
Scientists discover how to revive exhausted immune cells, boosting defenses against infections and cancer in aging bodies.
The FDA expands its digital health pilot with Cadence, testing AI-driven hypertension tools in real-world settings without premarket approval.
BD completes enrollment for hernia mesh trial to compare Phasix mesh with standard suture closure for lowering postoperative hernias incidence.